← Leaderboards
Min Sup Song
University Of Tx Md Anderson Can Ctr
$4,833,294
Attributed
$4,833,294
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $775.6K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,833,294 · 2
By mechanism
R01$4,833,294 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Guocan Wang$2,004,125
- Glen Traver Hart$5,258,043
- Di Zhao$3,648,377
- Rehan Akbani$4,444,254
- Han Liang$9,209,663
Others in their field
Top investigators on “Improved Outcome”
- Chanza Baytop · Westat, Inc.$271,217,917
- Gregory H Reaman · National Childhood Cancer Foundation$206,587,183
- Mary M Horowitz · Medical College Of Wisconsin$182,617,394
- Judith S Hochman · New York University School Of Medicine$160,639,636
- Elizabeth A Thom · George Washington University$158,102,350
- Walter John Curran · Thomas Jefferson University$153,383,852
Research focus
Improved OutcomeTumorPathway InteractionsPublic HealthMalignant NeoplasmsMolecularLinkMissionPathologicUnited States National Institutes Of HealthCancer TherapyQuality Of LifeClinical ApplicationLaboratoriesMedicalGenetic AnalysisPatient-Focused OutcomesGeneticBiologyTherapeutic InterventionVariantModificationResistanceMediating
Grant awards (13)
The role of PTEN feedback mechanism in cancer$405,000
R01 · FY2025 · CA · contact PI
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer$370,575
R01 · FY2025 · CA · contact PI
The role of PTEN feedback mechanism in cancer$384,750
R01 · FY2024 · CA · contact PI
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer$352,047
R01 · FY2024 · CA · contact PI
The role of PTEN feedback mechanism in cancer$405,000
R01 · FY2023 · CA · contact PI
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer$363,164
R01 · FY2023 · CA · contact PI
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer$363,164
R01 · FY2022 · CA · contact PI
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer$370,575
R01 · FY2021 · CA · contact PI
The role of PTEN feedback mechanism in cancer$366,000
R01 · FY2020 · CA · contact PI
The role of PTEN feedback mechanism in cancer$355,019
R01 · FY2019 · CA · contact PI
The role of PTEN feedback mechanism in cancer$366,000
R01 · FY2018 · CA · contact PI
The role of PTEN feedback mechanism in cancer$366,000
R01 · FY2017 · CA · contact PI
The role of PTEN feedback mechanism in cancer$366,000
R01 · FY2016 · CA · contact PI